title: Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update.
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX; University of Chicago, Chicago, IL; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Jessica P
authors.initials: JP
authors.lastname: Hwang
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX; University of Chicago, Chicago, IL; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Artz
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX; University of Chicago, Chicago, IL; and American Society of Clinical Oncology, Alexandria, VA.
authors.forename: Mark R
authors.initials: MR
authors.lastname: Somerfield
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006515:Hepatitis B virus / Q000502:physiology; D019694:Hepatitis B, Chronic / Q000175:diagnosis* / Q000188:drug therapy*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D017410:Practice Guidelines as Topic; D014775:Virus Activation
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents